Molecule Details
InChIKeyVZYCZNZBPPHOFY-UHFFFAOYSA-N
Compound NameThioproperazine
Canonical SMILESCN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)2
Pfam Stratification Homologous
Avg pChEMBL9.13
SourceBindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01622
Drug NameThioproperazine
CAS Number316-81-4
Groups approved
ATC Codes N05AB08
DescriptionThioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihis...

Categories: Adrenergic Antagonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Agents that produce hypertension Antidepressive Agents Antipsychotic Agents Antipsychotic Agents (First Generation [Typical]) Central Nervous System Depressants Dopamine Antagonists Dopamine D2 Receptor Antagonists Heterocyclic Compounds, Fused-Ring Nervous System Neurotoxic agents Phenothiazines Phenothiazines With Piperazine Structure Psycholeptics Serotonin 5-HT1 Receptor Antagonists Serotonin 5-HT2 Receptor Antagonists Serotonin Agents Serotonin Receptor Antagonists Sulfur Compounds
Cross-references: BindingDB: 81793 ChEBI: 59120 CHEMBL609109 ChemSpider: 9058 Drugs Product Database (DPD): 7999 D08585 PharmGKB: PA164754875 PubChem:9429 PubChem:46507111 RxCUI: 10498 Wikipedia: Thioproperazine ZINC: ZINC000022446685
Target Activities (2)
Target Gene Organism Category Pfam pChEMBL Type Source
P14416 DRD2 Homo sapiens Human PF00001 9.3 Ki BindingDB
P35462 DRD3 Homo sapiens Human PF00001 8.9 Ki BindingDB
DrugBank Target Actions (5)
Target Gene Target Name Action Type
P02768 ALB Albumin binder carriers
P14416 DRD2 D(2) dopamine receptor antagonist targets
P21728 DRD1 D(1A) dopamine receptor antagonist targets
P35348 ADRA1A Alpha-1A adrenergic receptor antagonist targets
P35368 ADRA1B Alpha-1B adrenergic receptor antagonist targets